Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Patient Management
100%
Euro
100%
Acute Myocardial Infarction
100%
Regional Variation
100%
European Society of Cardiology
40%
In-hospital Mortality
40%
Europe
20%
ST-elevation Myocardial Infarction (STEMI)
20%
Statins
20%
Baseline Characteristics
20%
Sweden
20%
Wales
20%
Population Characteristics
20%
National Registry
20%
Beta-blockers
20%
Aspirin
20%
Fibrinolysis
20%
Anticoagulants
20%
Low Molecular Weight Heparin
20%
Electronic Form
20%
Population Management
20%
In-hospital Outcomes
20%
Thienopyridines
20%
Management Outcome
20%
Population Outcomes
20%
Angiotensin-converting Enzyme Inhibitor (ACEi)
20%
Primary Percutaneous Coronary Intervention (pPCI)
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
100%
Hospital Mortality
33%
Beta Adrenergic Receptor Blocking Agent
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
ST Segment Elevation Myocardial Infarction
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Acetylsalicylic Acid
16%
Anticoagulant Agent
16%
Low Molecular Weight Heparin
16%
Thienopyridine
16%
Nursing and Health Professions
Acute Heart Infarction
100%
Hospital Mortality
33%
ST Segment Elevation Myocardial Infarction
16%
Percutaneous Coronary Intervention
16%
Beta Adrenergic Receptor Blocking Agent
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Anticoagulant Agent
16%
Dipeptidyl Carboxypeptidase Inhibitor
16%
Thienopyridine Derivative
16%
Low Molecular Weight Heparin
16%